ArifIDalviMDMBA

Neurology • Boynton Beach, FL

Movement Disorder, Neurodegenerative

Director, Comprehensive Movement Disorders Program Palm Beach Neuroscience Institute West Palm Beach, FL

Join to view full profile

Dr. Dalvi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dalvi's full profile

Already have an account?

Office
8756 Boynton Beach Blvd
Ste 2300
Boynton Beach, FL 33472
Phone+1 561-882-6214

Fax+1 561-882-6216
Is this information wrong?

Education & Training

University of Cincinnati College of Medicine1997 - 1998
Columbia University Vagelos College of Physicians and Surgeons1996 - 1997
University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 1993 - 1996
Huron HospitalInternship, Internal Medicine, 1992 - 1993
Rural Medical College Pravara Institute of Medical SciencesClass of 1991

Certifications & Licensure

FL State Medical License 2014 - 2026
IL State Medical License 2002 - 2020
IN State Medical License 2013 - 2019
OH State Medical License 1997 - 2003
UT State Medical License 1995 - 1998
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Clinical Trials

Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa Start of enrollment: 2005 Mar 01
Completed
Phase 3
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease Start of enrollment: 2018 Feb 09
Active, not recruiting
Not Applicable
Azilect + Antidepressant Chart Review Start of enrollment: 2009 Jul 01
Completed
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis Start of enrollment: 2010 Jul 01
Completed
Phase 3
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease Start of enrollment: 2002 Mar 01
Terminated
Phase 2, Phase 3
A Longitudinal Observational Follow-up of the PRECEPT Study Cohort Start of enrollment: 2006 Aug 01
Unknown status
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease Start of enrollment: 2018 Sep 28
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

14 citations
Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.
Krishna, V., Fishman, P., Eisenberg, H., Kaplitt, M., Baltuch, G., Chang, J., Chang, W., Martinez Fernandez, R., Del Alamo, M., Halpern, C., Ghanouni, P., Eleopra, R.,...> ;The New England Journal of Medicine. 2023 Feb 23
13 citations
Wilson's disease: etiology, diagnosis, and treatment
Arif Dalvi, Mahesh Padmanaban> ;Disease-a-Month. 2014 Sep 1
7 citations
Wilson’s disease: Neurological and psychiatric manifestations
Arif Dalvi> ;Disease-a-Month. 2014 Sep 1
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H,...> ;Nature genetics. 2014-07-27
2 citations
Alzheimer's disease.
Arif Dalvi> ;Disease-a-Month. 2012 Dec 1
Parkinsonism.
Dalvi A> ;Dis Mon. 2012 Dec
Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson'...
Elm JJ> ;Mov Disord. 2012 Oct
Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's di...
Lew MF Somogyi M McCague K Welsh M> ;Int J Neurosci. 2011 Nov
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
Marras C McDermott MP Marek K Rochon P Naglie G Tanner CM Rudolph A Shoulson I Lang AE> ;Mov Disord. 2011 Mar
Pediatric tremor.
Arif Dalvi> ;Disease-a-Month. 2011 Mar 1
7 citations
Tremor: etiology, phenomenology, and clinical features.
Arif Dalvi, Ashvini Premkumar> ;Disease-a-Month. 2011 Mar 1
Essential tremor--not just a shake.
Arif Dalvi, Michael G. Mercury> ;Disease-a-Month. 2011 Mar 1
Medical treatment of tremor.
Arif Dalvi> ;Disease-a-Month. 2011 Mar 1
2 citations
Surgical treatment of tremor.
Kevin Novak, Arif Dalvi, Emmanuel K. Nenonene, Lawrence P. Bernstein> ;Disease-a-Month. 2011 Mar 1
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
Schwid SR Bausch J Oakes D Schuchter L Tanner C Forrest M Lang AE Shoulson I Shoulson I Hyson C Oakes D Flagg E Rudolph A Kieburtz K Lang A Fahn S Gaug...> ;Mov Disord. 2010 Sep 15
A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.
Marras C Lang AE Eberly SW Oakes D Fahn S Schwid SR Hyson C Shoulson I> ;Mov Disord. 2009 Dec 15
45 citations
Dystonic storm due to Batten's disease treated with pallidotomy and deep brain stimulation.
Muruvet Elkay, Kenneth Silver, Richard D. Penn, Arif Dalvi> ;Movement Disorders. 2009 May 15
88 citations
Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
Robert A. Hauser, Mark F. Lew, Howard I. Hurtig, William G. Ondo, Joanne Wojcieszek, Cheryl Fitzer-Attas, Frederick J. Marshall, Irenita Gardiner, Nancy Pearson, Debra...> ;Movement Disorders. 2009 Mar 15
3894 citations
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B. Ster...> ;Movement Disorders. 2008 Nov 15
61 citations
A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes
Theresa E. Pretto, Arif Dalvi, Un Jung Kang, Richard D. Penn> ;Journal of Neurosurgery. 2008 Sep 1
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
Schwarzschild MA Schwid SR Marek K Watts A Lang AE Oakes D Shoulson I Ascherio A Hyson C Gorbold E Rudolph A Kieburtz K Fahn S Gauger L Goetz C Seibyl J...> ;Arch Neurol. 2008 Jun
8 citations
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation
William C. Nichols, Diane K. Marek, Michael W. Pauciulo, Nathan Pankratz, Cheryl Halter, Alice Rudolph, Clifford W. Shults, Joanne Wojcieszek, Tatiana Foroud, Cliff Sh...> ;Movement Disorders. 2007 Jan 15
2 citations
GDNF in treatment of Parkinson's disease: response to editorial.
Anthony E Lang, J William Langston, A Jon Stoessl, Matthew Brodsky, David J Brooks, Vijay Dhawan, William J Elias, Andres M Lozano, Elena Moro, John G Nutt, Dennis Tur...> ;The Lancet. Neurology. 2006 Mar 1
697 citations
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Anthony E. Lang, Steven S. Gill, Nik K. Patel, Andres M. Lozano, John G. Nutt, Richard D. Penn, David J. Brooks, Gary Hotton, Elena Moro, Peter Heywood, Matthew Brodsk...> ;Annals of Neurology. 2006 Mar 1
2 citations
GDNF in treatment of Parkinson's disease: response to editorial.
Richard D Penn, Arif Dalvi, John Slevin, Byron Young, Don Gash, Greg Gerhardt, Michael Hutchinson> ;The Lancet. Neurology. 2006 Mar 1
Join now to see all

Press Mentions

1 in 10 Seniors Has Dementia—Here’s Why That Matters Even if You’re in Your 20s, 30s, or 40sNovember 5th, 2022
This Surgery Is Giving Some Patients with Parkinson's Disease Their Lives BackMay 6th, 2021
APDA South Florida Chapter Presents “A Comprehensive Approach to Parkinson’s Disease” at Boca Raton MarriottDecember 25th, 2019
Join now to see all